| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Ryan Arthur F serves as a Director at REGN. Across recent SEC filings that breaks down to 0 buys and 490 sells. Those positions are worth an estimated $11.2M at current prices.
Historically, Ryan Arthur F's trades have earned a middling insider score of 54/100 across 38 rated trades. Over a 12-month horizon, 37.8% of those trades were profitable, with an average 12-month return of -2.1%.
The biggest single holding is REGN (~$11.2M) as Director. The recent filings there lean toward selling, a net 14,196 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $564.50 | $56,450.22 | -0.4% | +5.6% | +3.6% | |
| Jun 14, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $524.76 | $52,476.00 | -0.4% | +20.9% | +3.7% | |
| Feb 1, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $506.92 | $50,692.18 | -0.4% | - | - | |
| Jan 4, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $483.60 | $48,360.13 | -0.4% | - | - | |
| Dec 1, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $520.48 | $52,047.88 | -0.4% | - | - | |
| Nov 2, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $548.54 | $54,854.30 | -0.4% | - | - | |
| Oct 1, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $558.13 | $55,813.43 | -0.4% | - | - | |
| Sep 1, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $604.58 | $60,458.30 | -0.4% | - | - | |
| Aug 3, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $641.93 | $64,193.41 | -0.3% | - | - | |
| Jul 1, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $609.70 | $60,969.65 | -0.3% | - | - |